Fierens L, Liefferinckx C, Hoefkens E, Lobaton T, et al. Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies. J Crohns Colitis 2022;16:1059-1069.
PMID: 35078228